Home/Filings/4/0001013762-13-001487
4//SEC Filing

DelMar Pharmaceuticals, Inc. 4

Accession 0001013762-13-001487

$HURACIK 0001498382operating

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 1:50 PM ET

Size

7.0 KB

Accession

0001013762-13-001487

Insider Transaction Report

Form 4
Period: 2013-11-26
Transactions
  • Conversion

    Warrants (Right to Buy)

    2013-11-265,00045,000 total(indirect: By LLC)
    Exercise: $1.20From: 2011-10-03Exp: 2014-01-25Common Stock (5,000 underlying)
  • Conversion

    Common Stock

    2013-11-26+5,00010,000 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Warrants were exercised for no additional consideration. The exercise price of the remaining warrants is $1.20.
  • [F2]5,000 shares are held directly and 5,000 shares are held by EGB Advisors, LLC, which is owned by Mr. Garner.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001498382

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 1:50 PM ET
Size
7.0 KB